Etanercept. Immunex.

@article{Pugsley2001EtanerceptI,
  title={Etanercept. Immunex.},
  author={Michael K. Pugsley},
  journal={Current opinion in investigational drugs},
  year={2001},
  volume={2 12},
  pages={1725-31}
}
Immunex has developed and launched etanercept, a soluble TNF receptor (TNFR) fusion protein, for the treatment of rheumatoid arthritis (RA). It has also been developed for various TNF-mediated conditions such as congestive heart failure, endometriosis and multiple sclerosis. Etanercept has been launched as a second-line agent in the US for the treatment of… CONTINUE READING